ACHV logo

Achieve Life Sciences (ACHV) Shareholders Equity

Annual Shareholders Equity

-$1.45 M
-$9.75 M-117.44%

31 December 2023

ACHV Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$31.38 M
-$10.91 M-25.79%

30 September 2024

ACHV Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ACHV Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-117.4%+677.1%
3 y3 years-103.9%-9.6%
5 y5 years-109.2%+285.4%

ACHV Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-103.9%at low-36.5%+2267.0%
5 y5 years-103.9%at low-36.5%+2267.0%
alltimeall time-102.2%+83.9%-59.8%+365.9%

Achieve Life Sciences Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$31.38 M(-25.8%)
June 2024
-
$42.28 M(-14.5%)
Mar 2024
-
$49.46 M(-3515.5%)
Dec 2023
-$1.45 M(-117.4%)
-$1.45 M(-135.9%)
Sept 2023
-
$4.04 M(-58.4%)
June 2023
-
$9.70 M(+2089.4%)
Mar 2023
-
$443.00 K(-94.7%)
Dec 2022
$8.30 M(-70.4%)
$8.30 M(+695.3%)
Sept 2022
-
$1.04 M(-92.1%)
June 2022
-
$13.17 M(-38.6%)
Mar 2022
-
$21.43 M(-23.6%)
Dec 2021
$28.04 M(-24.8%)
$28.04 M(-19.2%)
Sept 2021
-
$34.70 M(-15.1%)
June 2021
-
$40.85 M(+35.8%)
Mar 2021
-
$30.09 M(-19.3%)
Dec 2020
$37.29 M(+106.6%)
$37.29 M(+45.2%)
Sept 2020
-
$25.68 M(+76.6%)
June 2020
-
$14.54 M(-3.0%)
Mar 2020
-
$14.98 M(-17.0%)
Dec 2019
$18.05 M(+14.2%)
$18.05 M(+121.7%)
Sept 2019
-
$8.14 M(-29.2%)
June 2019
-
$11.50 M(+12.9%)
Mar 2019
-
$10.19 M(-35.5%)
Dec 2018
$15.80 M(+100.6%)
$15.80 M(+11.6%)
Sept 2018
-
$14.16 M(-13.9%)
June 2018
-
$16.44 M(+167.7%)
Mar 2018
-
$6.14 M(-22.0%)
Dec 2017
$7.88 M(+1191.6%)
$7.88 M(-26.2%)
Sept 2017
-
$10.68 M(-18.5%)
June 2017
-
$13.10 M(-17.5%)
Mar 2017
-
$15.89 M(+2505.1%)
Dec 2016
$610.00 K(-98.4%)
$610.00 K(-97.5%)
Sept 2016
-
$24.42 M(-13.6%)
June 2016
-
$28.25 M(-17.4%)
Mar 2016
-
$34.22 M(-8.6%)
Dec 2015
$37.44 M(+9.9%)
$37.44 M(-3.4%)
Sept 2015
-
$38.77 M(+37.5%)
June 2015
-
$28.19 M(-6.1%)
Mar 2015
-
$30.02 M(-11.9%)
Dec 2014
$34.06 M(-8.5%)
$34.06 M(-12.3%)
Sept 2014
-
$38.85 M(+46.8%)
June 2014
-
$26.46 M(-10.6%)
Mar 2014
-
$29.60 M(-20.4%)
Dec 2013
$37.21 M(-43.8%)
$37.21 M(-14.5%)
Sept 2013
-
$43.54 M(-17.4%)
June 2013
-
$52.69 M(-12.6%)
Mar 2013
-
$60.27 M(-9.0%)
Dec 2012
$66.21 M(+114.3%)
$66.21 M(-5.1%)
Sept 2012
-
$69.76 M(-6.6%)
June 2012
-
$74.72 M(-4.4%)
Mar 2012
-
$78.13 M(+152.9%)
Dec 2011
$30.89 M(-30.0%)
$30.89 M(-22.8%)
Sept 2011
-
$40.02 M(+13.7%)
June 2011
-
$35.20 M(-15.2%)
Mar 2011
-
$41.50 M(-6.0%)
Dec 2010
$44.13 M(+92.2%)
$44.13 M(+208.5%)
Sept 2010
-
$14.30 M(-31.6%)
June 2010
-
$20.90 M(+3.1%)
Mar 2010
-
$20.27 M(-11.7%)
DateAnnualQuarterly
Dec 2009
$22.96 M(+114.4%)
$22.96 M(+108.6%)
Sept 2009
-
$11.01 M(+179.5%)
June 2009
-
$3.94 M(-53.1%)
Mar 2009
-
$8.39 M(-21.6%)
Dec 2008
$10.71 M(-66.4%)
$10.71 M(-30.8%)
Sept 2008
-
$15.48 M(-36.9%)
June 2008
-
$24.52 M(-12.8%)
Mar 2008
-
$28.10 M(-11.9%)
Dec 2007
$31.90 M(-25.9%)
$31.90 M(+7.8%)
Sept 2007
-
$29.59 M(-16.2%)
June 2007
-
$35.32 M(-12.4%)
Mar 2007
-
$40.33 M(-6.3%)
Dec 2006
$43.04 M(+22.1%)
$43.04 M(-12.5%)
Sept 2006
-
$49.18 M(-10.6%)
June 2006
-
$55.01 M(+79.4%)
Mar 2006
-
$30.66 M(-13.1%)
Dec 2005
$35.26 M(+84.8%)
$35.26 M(+85.1%)
Sept 2005
-
$19.05 M(+83.7%)
June 2005
-
$10.37 M(-27.7%)
Mar 2005
-
$14.34 M(-24.8%)
Dec 2004
$19.08 M(-1.2%)
$19.08 M(-21.9%)
Sept 2004
-
$24.42 M(-12.6%)
June 2004
-
$27.94 M(+67.6%)
Mar 2004
-
$16.67 M(-13.7%)
Dec 2003
$19.31 M(+22.8%)
$19.31 M(-8.7%)
Sept 2003
-
$21.15 M(+103.2%)
June 2003
-
$10.41 M(-22.9%)
Mar 2003
-
$13.49 M(-14.2%)
Dec 2002
$15.72 M(+7.2%)
$15.72 M(-13.2%)
Sept 2002
-
$18.12 M(-15.2%)
June 2002
-
$21.37 M(-13.9%)
Mar 2002
-
$24.83 M(+69.3%)
Dec 2001
$14.67 M(+72.3%)
$14.67 M(-9.1%)
Sept 2001
-
$16.13 M(+52.9%)
June 2001
-
$10.55 M(+35.2%)
Mar 2001
-
$7.80 M(-8.3%)
Dec 2000
$8.51 M(-15.3%)
$8.51 M(+1.6%)
Sept 2000
-
$8.38 M(-20.5%)
June 2000
-
$10.54 M(+24.3%)
Mar 2000
-
$8.47 M(-15.7%)
Dec 1999
$10.05 M(+34.0%)
$10.05 M(+41.5%)
Sept 1999
-
$7.10 M(+39.2%)
June 1999
-
$5.10 M(-16.4%)
Mar 1999
-
$6.10 M(-18.7%)
Dec 1998
$7.50 M(-59.5%)
$7.50 M(-26.5%)
Sept 1998
-
$10.20 M(-17.1%)
June 1998
-
$12.30 M(-19.6%)
Mar 1998
-
$15.30 M(-17.3%)
Dec 1997
$18.50 M(+10.1%)
$18.50 M(+3.4%)
Sept 1997
-
$17.90 M(-5.3%)
June 1997
-
$18.90 M(+3.3%)
Mar 1997
-
$18.30 M(+8.9%)
Dec 1996
$16.80 M(+54.1%)
$16.80 M(+18.3%)
Sept 1996
-
$14.20 M(+25.7%)
June 1996
-
$11.30 M(+79.4%)
Mar 1996
-
$6.30 M(-42.2%)
Dec 1995
$10.90 M(-221.1%)
$10.90 M(-192.4%)
Sept 1995
-
-$11.80 M(+31.1%)
Dec 1994
-$9.00 M
-$9.00 M

FAQ

  • What is Achieve Life Sciences annual stockholders equity?
  • What is the all time high annual shareholders equity for Achieve Life Sciences?
  • What is Achieve Life Sciences annual shareholders equity year-on-year change?
  • What is Achieve Life Sciences quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Achieve Life Sciences?
  • What is Achieve Life Sciences quarterly shareholders equity year-on-year change?

What is Achieve Life Sciences annual stockholders equity?

The current annual shareholders equity of ACHV is -$1.45 M

What is the all time high annual shareholders equity for Achieve Life Sciences?

Achieve Life Sciences all-time high annual stockholders equity is $66.21 M

What is Achieve Life Sciences annual shareholders equity year-on-year change?

Over the past year, ACHV annual stockholders equity has changed by -$9.75 M (-117.44%)

What is Achieve Life Sciences quarterly stockholders equity?

The current quarterly shareholders equity of ACHV is $31.38 M

What is the all time high quarterly shareholders equity for Achieve Life Sciences?

Achieve Life Sciences all-time high quarterly stockholders equity is $78.13 M

What is Achieve Life Sciences quarterly shareholders equity year-on-year change?

Over the past year, ACHV quarterly stockholders equity has changed by +$27.34 M (+677.07%)